Sequana Medical NV: Sequana Medical announces H1 2023 results and provides business update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION14 September 2023, 07:00 CEST alfapump® – strong pivotal POSEIDON data presented at leading international liver congress / on track to file Pre-Market
PRESS RELEASE Phase 1 clinical trial (CHIHUAHUA) demonstrates that single dose of second-generation DSR product (DSR 2.0) is safe and well-tolerated, and indicates a compelling dosing profileOn
PRESS RELEASEREGULATED INFORMATION09 February 2023, 07:00 CEST alfapump® - successful primary endpoint read-out of North American pivotal POSEIDON study / PMA1 filing planned for H2 2023DSR®
PRESS RELEASE Data from GLPi animal studies demonstrate safety of second-generation DSRii product (DSR 2.0)Data from Phase 1 study of DSR 2.0 in Mexico (CHIHUAHUA) and INDiii filing